← Back to directory

Roberta Rudà

Researcher Next ID · RN-040067

Researcher · Biochemistry, Genetics and Molecular Biology

CTO Hospital

Turin, Austria

Accepting doctoral researchersFunding unknown
Works count
566
Citation count
16,127
H-index
61
i10-index
173

Research interests

Biochemistry, Genetics and Molecular Biology
Medicine
Glioma Diagnosis and Treatment
Brain Metastases and Treatment
Meningioma and schwannoma management
Radiomics and Machine Learning in Medical Imaging
Cancer, Hypoxia, and Metabolism

Publications

  • Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study

    The Lancet Oncology · 2021 · https://doi.org/10.1016/s1470-2045(21)00090-5

  • EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood

    Nature Reviews Clinical Oncology · 2020 · 10.1038/s41571-020-00447-z

  • The RANO Leptomeningeal Metastasis Group proposal to assess response to treatment: lack of feasibility and clinical utility and a revised proposal

    Neuro-Oncology · 2019 · https://doi.org/10.1093/neuonc/noz024

  • European Association for Neuro-Oncology (EANO) guidelines for palliative care in adults with glioma

    The Lancet Oncology · 2017 · https://doi.org/10.1016/s1470-2045(17)30345-5

  • Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study

    The Lancet · 2017 · https://doi.org/10.1016/s0140-6736(17)31442-3

  • EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours

    Annals of Oncology · 2017 · https://doi.org/10.1093/annonc/mdx221

  • Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial

    The Lancet Haematology · 2016 · https://doi.org/10.1016/s2352-3026(16)00036-3

  • Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO)

    Neuro-Oncology · 2016 · https://doi.org/10.1093/neuonc/now241

  • Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology

    The Lancet Oncology · 2015 · https://doi.org/10.1016/s1470-2045(15)00076-5

Current projects

    No projects listed.